1Herttuala S,Palinski W,Rosenfeld M E,et al.Evidence for the presence of oxidatively modified low deneity lipoprotein in atheroslerotic lesions of rabbit and man[J].J Clin Invest,1989,84:1086.
2Schewertner H A,Jackson W G,Tolan G.Association of low werum concentration of bilirubin with increased risk of coronary artery disease[J].Clin Chem,1994,40:18.
3Brelmer L H,Wannamethee G,Erbranim S,et al.In middle-aged Britishmen[J].Clin Chem,1995,41(10):1504-1508.
4Erdogan D,Gullu H,Yildirim E,et al.Low serum bilirubin levels are independently and inversely related to impaired flow mediated vasodilation and increased carotid intima media thickness in both men and women[J].Atherosclerosis,2006,184(2):431-437.
2Stocker R, Yamanoto Y, Medonagh AF, et al. Bilirubin is an antioxidant possible physiological irnportance[J]. Science, 1987, 235(4792) : 1043 - 1046.
3Schwertner HA. Bilirubin concentration, UGT1A1 * 28 polymorphism, and coronary artery disease[J]. Clinical Chemistry, 2003, 49(7): 1(139- 1040.
4Wu TW, Fung KP. Wu J. et al. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins[J]. Biochem Pharmacol, 1996, 51:859-862.
5Hopkins PN. Wu L L, Hunt SC, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease [J]. Arterioacler Thromb Vase Biol, 1996,16(2) :250 - 255.
6Nakagami T, Toyomura K, Kinoshita T, et al. h beneficial role of bile pigments as an endogenous tissue protector: antieomplement effects of biliverdin and conjugated bilirubin[J]. Biochim Biophys Acts, 1993, 1158 (2) : 189- 193.
1Cao ], Sodhi K,Quilley J,et al. Lentiviral-human heme oxygen-ase targeting endothelium improved vascular function in angio-tensin II animal model of hypertension [J]. Hum Gene Ther,2011,22(3):271-282.
2Ndisang J F . Jadhav A. Upregulating the heme oxygenase sys-tem suppresses left ventricular hypertrophy in adult spontane-ously hypertensive rats for 3 months[J]. J Card Fail, 2009 ,15(7):616-628.
3Yamashina A,Tomiyama H. Artherriosclerosis and pulse waveelocity[J]. Nippon Rinsho,2004,62(1) :80-86.
4Mancia G,De Backer G, Dominiczak A, et al. 2007 Guidelinesfor the management of arterial hypertension: The Task Forcefor the Management of Arterial Hypertension of the EuropeanSociety of Hypertension. (ESH) and of the European Society ofCardiology (ESC)[J]. Eur Heart J,2007,28(12) : 1462-1536.
5Vitek L,Novotny L,Sper L M,et al. The inverse association ofelevated serum bilirubin levels with subclinic carotid athero-sclerosis [J]. Cerebrovascular Diseases, 2006 , 21 (526): 408-414.
